{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo-+Serum", "query": { "intervention": "Placebo- Serum" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 968, "total_pages": 97, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo-+Serum&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-10T12:53:44.873Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02047552", "title": "RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Functional Iron Deficiency", "Trauma", "Anemia" ], "interventions": [ { "name": "Iron sucrose", "type": "DRUG" }, { "name": "Oxandrolone", "type": "DRUG" }, { "name": "IV iron placebo", "type": "DRUG" }, { "name": "Oxandrolone placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Denver Health and Hospital Authority", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2015-01", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2019-04-03", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02047552" }, { "nct_id": "NCT00257608", "title": "A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "bevacizumab", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "erlotinib HCl", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1145, "start_date": "2006-01", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2016-04-18", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 177, "location_summary": "Mobile, Alabama • Fort Smith, Arizona • Scottsdale, Arizona + 160 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Fort Smith", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Alhambra", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00257608" }, { "nct_id": "NCT00115778", "title": "Intravenous Immunoglobulin (IVIG) in Lung Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypogammaglobulinemia", "Lung Transplantation" ], "interventions": [ { "name": "IVIG", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "12 Years to 75 Years" }, "enrollment_count": 11, "start_date": "2005-06", "completion_date": "2010-08", "has_results": true, "last_update_posted_date": "2019-03-05", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00115778" }, { "nct_id": "NCT01300728", "title": "Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Mild Cognitive Impairment" ], "interventions": [ { "name": "NewGam 10% IVIG", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Sutter Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "50 Years to 84 Years" }, "enrollment_count": 52, "start_date": "2011-01-01", "completion_date": "2020-03-12", "has_results": true, "last_update_posted_date": "2022-10-27", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01300728" }, { "nct_id": "NCT04880577", "title": "Tenofovir Alafenamide for Treatment of Symptoms and Neuroprotection in Relapsing Remitting Multiple Sclerosis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Sclerosis, Relapsing-Remitting", "Fatigue" ], "interventions": [ { "name": "TENOFOVIR ALAFENAMIDE FUMARATE 25 Mg ORAL TABLET [VEMLIDY]", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2022-09-15", "completion_date": "2025-02-14", "has_results": false, "last_update_posted_date": "2022-11-15", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04880577" }, { "nct_id": "NCT00925600", "title": "Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cancer", "Cataract", "Low Bone Mineral Density", "Osteopenia", "Osteoporosis", "Prostate Cancer" ], "interventions": [ { "name": "Denosumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "120 Years", "sex": "MALE", "summary": "30 Years to 120 Years · Male only" }, "enrollment_count": 769, "start_date": "2009-11-30", "completion_date": "2016-05-12", "has_results": true, "last_update_posted_date": "2017-05-30", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 52, "location_summary": "Anaheim, California • Laguna Hills, California • Murrieta, California + 45 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Murrieta", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00925600" }, { "nct_id": "NCT03383458", "title": "A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hepatocellular Carcinoma", "Liver Cancer" ], "interventions": [ { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 545, "start_date": "2018-04-18", "completion_date": "2031-05-27", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 28, "location_summary": "Anniston, Alabama • Phoenix, Arizona • Tucson, Arizona + 21 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03383458" }, { "nct_id": "NCT05604521", "title": "A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malaria", "Malaria,Falciparum" ], "interventions": [ { "name": "PfSPZ Vaccine", "type": "BIOLOGICAL" }, { "name": "PfSPZ Challenge (7G8)", "type": "BIOLOGICAL" }, { "name": "Normal Saline", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Sanaria Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 31, "start_date": "2022-12-06", "completion_date": "2023-09-05", "has_results": true, "last_update_posted_date": "2024-11-25", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05604521" }, { "nct_id": "NCT07810504", "title": "Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Androgenic Alopecia", "Female Pattern Hair Loss", "Hair Loss" ], "interventions": [ { "name": "Scalp Stimulating Serum", "type": "OTHER" }, { "name": "Red Light Hair Growth Cap", "type": "DEVICE" }, { "name": "Placebo scalp-stimulating serum", "type": "OTHER" } ], "intervention_types": [ "OTHER", "DEVICE" ], "sponsor": "K. Kay Durairaj, MD, FACS, A Medical Corporation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "35 Years to 55 Years · Female only" }, "enrollment_count": 40, "start_date": "2026-03-17", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-09-09", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 1, "location_summary": "Pasadena, California", "locations": [ { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07810504" }, { "nct_id": "NCT02538666", "title": "An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lung Cancer" ], "interventions": [ { "name": "Nivolumab", "type": "BIOLOGICAL" }, { "name": "Ipilimumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 907, "start_date": "2015-10-13", "completion_date": "2021-11-11", "has_results": true, "last_update_posted_date": "2023-01-05", "last_synced_at": "2026-09-10T12:53:44.873Z", "location_count": 28, "location_summary": "Sacramento, California • New Haven, Connecticut • Fort Myers, Florida + 23 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Fort Myers", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02538666" } ] }